Table Of Contents:
1. Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
2. How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
3. Performing a United States Pharmacopeia Chapter Compliant Assessment of Risk
4. New and Improved!
5. Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
6. Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
7. Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
8. Calculations
9. Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
10. Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
11. Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
12. Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
13. Isoniazid 10 mg/mL in SyrSpend SF pH4
14. LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
15. Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
16. Potassium Chloride 1 mmol/mL in Ora-Sweet SF
17. Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
18. Venlafaxine 15 mg/mL in Syrup
19. Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit
20. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
21. Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
22. Compatibility of Melphalan in Iodinated Contrast Media